Oncolytic viruses for cancer immunotherapy

被引：0
|
作者：
Otto Hemminki
João Manuel dos Santos
Akseli Hemminki
机构：
[1] University Health Network and University of Toronto,Division of Urologic Oncology, Department of Surgical Oncology, Princess Margaret Cancer Centre
[2] University of Helsinki,Cancer Gene Therapy Group, Translational Immunology Research Program
[3] Helsinki University Hospital,Department of Urology
[4] TILT Biotherapeutics Ltd,undefined
[5] Helsinki University Hospital Comprehensive Cancer Center,undefined
来源：
Journal of Hematology & Oncology | / 13卷
关键词：
Adenovirus; Oncolytic; Tumor; Cancer; Immunotherapy; Review; Immunology; Immune system; Immunosupression;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
In this review, we discuss the use of oncolytic viruses in cancer immunotherapy treatments in general, with a particular focus on adenoviruses. These serve as a model to elucidate how versatile viruses are, and how they can be used to complement other cancer therapies to gain optimal patient benefits. Historical reports from over a hundred years suggest treatment efficacy and safety with adenovirus and other oncolytic viruses. This is confirmed in more contemporary patient series and multiple clinical trials. Yet, while the first viruses have already been granted approval from several regulatory authorities, room for improvement remains.
引用
收藏
相关论文
共 50 条
  • [21] Oncolytic virotherapy as promising immunotherapy against cancer: mechanisms of resistance to oncolytic viruses
    Goradel, Nasser Hashemi
    Alizadeh, Arezoo
    Hosseinzadeh, Shahnaz
    Taghipour, Mitra
    Ghesmati, Zeinab
    Arashkia, Arash
    Negahdari, Babak
    FUTURE ONCOLOGY, 2021, 18 (02) : 245 - 259
  • [22] Fusogenic Viruses in Oncolytic Immunotherapy
    Krabbe, Teresa
    Altomonte, Jennifer
    CANCERS, 2018, 10 (07):
  • [23] Author Correction: Integrating oncolytic viruses in combination cancer immunotherapy
    Praveen K. Bommareddy
    Megha Shettigar
    Howard L. Kaufman
    Nature Reviews Immunology, 2018, 18 : 536 - 536
  • [24] Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
    Omid Hamid
    Brianna Hoffner
    Eduard Gasal
    Jenny Hong
    Richard D. Carvajal
    Cancer Immunology, Immunotherapy, 2017, 66 : 1249 - 1264
  • [25] Tutorial: design, production and testing of oncolytic viruses for cancer immunotherapy
    Gujar, Shashi
    Pol, Jonathan G.
    Kumar, Vishnupriyan
    Lizarralde-Guerrero, Manuela
    Konda, Prathyusha
    Kroemer, Guido
    Bell, John C.
    NATURE PROTOCOLS, 2024, : 2540 - 2570
  • [26] Oncolytic immunotherapy: unlocking the potential of viruses to help target cancer
    Hamid, Omid
    Hoffner, Brianna
    Gasal, Eduard
    Hong, Jenny
    Carvajal, Richard D.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2017, 66 (10) : 1249 - 1264
  • [27] Oncolytic viruses: a novel form of immunotherapy
    Prestwich, Robin J.
    Harrington, Kevin J.
    Pandha, Hardev S.
    Vile, Richard G.
    Melcher, Alan A.
    Errington, Fiona
    EXPERT REVIEW OF ANTICANCER THERAPY, 2008, 8 (10) : 1581 - 1588
  • [28] Combined immunotherapy using oncolytic viruses
    Kojima, Takashi
    CANCER SCIENCE, 2022, 113 : 861 - 861
  • [29] Perspectives on immunotherapy via oncolytic viruses
    Alberto Reale
    Adriana Vitiello
    Valeria Conciatori
    Cristina Parolin
    Arianna Calistri
    Giorgio Palù
    Infectious Agents and Cancer, 14
  • [30] Perspectives on immunotherapy via oncolytic viruses
    Reale, Alberto
    Vitiello, Adriana
    Conciatori, Valeria
    Parolin, Cristina
    Calistri, Arianna
    Palu, Giorgio
    INFECTIOUS AGENTS AND CANCER, 2019, 14 (1)
12345